Topics

Global Monoethylene Glycol MEG Market Analysis 20122017 and Forecast 20182023 [Report Updated: 19012018] Prices from USD $2980

05:17 EST 3 Feb 2018 | BioPortfolio Reports

Summary

The global Monoethylene Glycol MEG market will reach xxx Million USD in 2017 and CAGR xx% 20112017. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Monoethylene Glycol MEG by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

0

Product Type Coverage Market Size Forecast, Major Company of Product Type etc.:

Fiber Grade

Industrial Grade

Antifreeze Grade

Company Coverage Sales Revenue, Price, Gross Margin, Main Products etc.:

SABIC

Sinopec

Formosa Plastics Group FPG

Shell

EQUATE

Lotte Chemical

Dow

SPDC

CNPC

Reliance Industries

OUCC

INEOS

LyondellBasell

BASF

NIOC

Farsa Chimie

PTT Global Chemical

IndianOil

Indorama Ventures

Sibur

PJSC Kazanorgsintez

Nippon Shokubai

SHAZAND Company

Huntsman

Maruzen Petrochemical

Application Coverage Market Size Forecast, Different Demand Market by Region, Main Consumer Profile etc.:

Polyester Fibre

Polyester Resins

Antifreeze and Coolants

Chemical Intermediates

Others

Region Coverage Regional Output, Demand Forecast by Countries etc.:

North America

Europe

AsiaPacific

South America

Middle East Africa

Original Article: Global Monoethylene Glycol MEG Market Analysis 20122017 and Forecast 20182023 [Report Updated: 19012018] Prices from USD $2980

NEXT ARTICLE

More From BioPortfolio on "Global Monoethylene Glycol MEG Market Analysis 20122017 and Forecast 20182023 [Report Updated: 19012018] Prices from USD $2980"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...